TitleThe chemistry and toxicology of vaping.
Publication TypeJournal Article
Year of Publication2021
AuthorsBonner, E, Chang, Y, Christie, E, Colvin, V, Cunningham, B, Elson, D, Ghetu, C, Huizenga, J, Hutton, SJ, Kolluri, SK, Maggio, S, Moran, I, Parker, B, Rericha, Y, Rivera, BN, Samon, S, Schwichtenberg, T, Shankar, P, Simonich, MT, Wilson, LB, Tanguay, RL
JournalPharmacol Ther
Volume225
Pagination107837
Date Published2021 09
ISSN1879-016X
KeywordsChemistry, Humans, Toxicology, Vaping
Abstract

Vaping is the process of inhaling and exhaling an aerosol produced by an e-cigarette, vape pen, or personal aerosolizer. When the device contains nicotine, the Food and Drug Administration (FDA) lists the product as an electronic nicotine delivery system or ENDS device. Similar electronic devices can be used to vape cannabis extracts. Over the past decade, the vaping market has increased exponentially, raising health concerns over the number of people exposed and a nationwide outbreak of cases of severe, sometimes fatal, lung dysfunction that arose suddenly in otherwise healthy individuals. In this review, we discuss the various vaping technologies, which are remarkably diverse, and summarize the use prevalence in the U.S. over time by youths and adults. We examine the complex chemistry of vape carrier solvents, flavoring chemicals, and transformation products. We review the health effects from epidemiological and laboratory studies and, finally, discuss the proposed mechanisms underlying some of these health effects. We conclude that since much of the research in this area is recent and vaping technologies are dynamic, our understanding of the health effects is insufficient. With the rapid growth of ENDS use, consumers and regulatory bodies need a better understanding of constituent-dependent toxicity to guide product use and regulatory decisions.

DOI10.1016/j.pharmthera.2021.107837
Alternate JournalPharmacol Ther
PubMed ID33753133
PubMed Central IDPMC8263470
Grant ListP30 ES030287 / ES / NIEHS NIH HHS / United States